智能手机事件记录仪联合标准诊疗用于急诊心悸或晕厥前患者的多中心随机对照试验:IPED研究方案
IPED研究为多中心开放标签随机对照试验,拟在英国10家医院招募242例急诊心悸或晕厥前且常规评估未明确心律诊断的成人患者,比较标准诊疗联合智能手机事件记录仪与单独标准诊疗在90天症状性心律检出率上的差异。该研究为首个评估此类设备在急诊人群应用的研究,旨在提高未明心律的诊断率。
要点
- 纳入急诊心悸或晕厥前、常规检查未明确心律诊断的≥16岁患者。
- 干预组在标准诊疗基础上使用智能手机事件记录仪,对照组仅标准诊疗。
- 主要终点为90天症状性心律检出率,分析基于意向性治疗原则。
核心结论
- 该研究旨在评估智能手机事件记录仪能否提高急诊心悸或晕厥前患者90天症状性心律检出率。
研究设计与样本
- 多中心、开放标签、随机对照试验,计划在英国10家医院招募242例 participant。
- 纳入标准:年龄≥16岁,急诊就诊时为心悸或晕厥前发作,临床评估后心律仍未明确诊断。
- 随机分为干预组(标准诊疗+智能手机事件记录仪)或对照组(仅标准诊疗)。
关键数值与推荐
- 主要终点:90天症状性心律检出率。
- 次要终点:临床、流程及成本效果指标。
- 分析集:意向性治疗(ITT)。
临床怎么用
- 对于急诊心悸或晕厥前且常规评估未明确心律的患者,可考虑使用智能手机事件记录仪在症状复发时记录心电图以辅助诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Palpitations and pre-syncope are together responsible for 300,000 annual Emergency Department (ED) attendances in the United Kingdom (UK). Diagnosis of the underlying rhythm is difficult as many patients are fully recovered on ED arrival; and examination and presenting electrocardiogram (ECG) are commonly normal. The only way to establish the underlying heart rhythm is to capture an ECG during symptoms. Recent technology advances have led to several novel ECG monitoring devices appearing on the market. This trial aims to compare the symptomatic rhythm detection rate at 90 days of one such smart phone-based event recorder (AliveCor Heart Monitor and AliveECG) with standard care for participants presenting to the ED with palpitations and pre-syncope and no obvious cause in the ED. METHODS/DESIGN: This is a multi-centre hospital ED / Acute Medical Unit (AMU) open label, randomised controlled trial. Participants will be recruited in 10 tertiary and district general hospitals in the UK. Participants aged ≥ 16 years presenting with an episode of palpitations or pre-syncope with no obvious cause and whose underlying ECG rhythm during these episodes remains undiagnosed after clinical assessment will be included. Participants will be randomised to either: (1) the intervention arm, standard care plus the use of a smart phone-based event recorder; or (2) the control arm, standard care. Primary endpoint will be symptomatic rhythm detection rate at 90 days. A number of secondary clinical, process and cost-effectiveness endpoints will be collected and analysed. Analysis will be on an intention-to-treat basis. DISCUSSION: The Investigation of Palpitations in the ED (IPED) study aims to recruit 242 participants across 10 hospital sites. It will be the first study to investigate the ability of a smart phone-based event recorder to detect symptomatic cardiac rhythms compared to standard care for ED patients with palpitations and pre-syncope with no obvious cause in the ED. This smart phone event recorder will allow ED patients who have presented with palpitations or pre-syncope to record their ECG tracing if they have a further episode and may increase the rate of underlying rhythm diagnosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02783898 . Registered on 26 May 2016.
引用
- Reed MJ, Grubb NR, Lang CC, et al. Multi-centre randomised controlled trial of a smart phone-based event recorder alongside standard care versus standard care for patients presenting to the Emergency Department with palpitations and pre-syncope - the IPED (Investigation of Palpitations in the ED) study: study protocol for a randomised controlled trial. Trials. 2018. PMID: 30594256. doi:10.1186/s13063-018-3098-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。